UBS raised the firm’s price target on C.H. Robinson (CHRW) to $133 from $129 and keeps a Buy rating on the shares. The company’s Q2 upside was driven by cost control and strong gross margins, the analyst tells investors in a research note. The firm says C.H. Robinson’s continued progress increases visibility on it achieving its targets.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHRW:
- CH Robinson: Strong Earnings and Technological Advances Amid Trade Policy Uncertainties Justify Hold Rating
- C.H. Robinson price target raised to $95 from $90 at Barclays
- C.H. Robinson Reports Strong Q2 2025 Performance
- C.H. Robinson reports Q2 adjusted EPS $1.29, consensus $1.16
- CHRW Upcoming Earnings Report: What to Expect?